Results of studies on investigational treatment for overactive bladder reported.(New Products)

Publication: Urologic Nursing

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2004 Jannetti Publications, Inc.

Yamanouchi Pharma America, Inc., a subsidiary of Yamanouchi Pharmaceutical Co., Ltd., a leading pharmaceutical company in Japan, has announced results from three placebo-controlled clinical trials, showing that solifenacin succinate, an investigational muscarinic antagonist currently under review by the U.S. Food and Drug Administration, may be useful in reducing the symptoms of...

Read the full article for free courtesy of your local library.